Multiple Myeloma and Colorectal Cancer



Similar documents
specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

FastTest. You ve read the book now test yourself

Supplemental Information. McBrayer et al. Supplemental Data

UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin Parsons, DO Gundersen Health System Center for Cancer and

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

CyTOF2. Mass cytometry system. Unveil new cell types and function with high-parameter protein detection

B cell activation and Humoral Immunity

Why discuss CLL? Common: 40% of US leukaemia. approx 100 pa in SJH / MWHB 3 inpatients in SJH at any time

Malignant Lymphomas and Plasma Cell Myeloma

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Activation and effector functions of HMI

Name (print) Name (signature) Period. (Total 30 points)

Microbiology AN INTRODUCTION EIGHTH EDITION

B Cells and Antibodies

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Uses of Flow Cytometry

Chapter 43: The Immune System

Flow Cytometry for Everyone Else Susan McQuiston, J.D., MLS(ASCP), C.Cy.

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

6/20/2014. PART I: Plasma Cell Myeloma. Plasma Cells

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

Plasma cell dyscrasias Mark Drayson

Multiple Myeloma Patient s Booklet

Bioinformatics for cancer immunology and immunotherapy

Monoclonal Gammopathy of Undetermined Significance (MGUS) Facts

Enhancing Anti-Tumor Activity of Checkpoint Inhibition

NATIONAL CANCER INSTITUTE. Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Autoimmunity and immunemediated. FOCiS. Lecture outline

Lymphoplasmacytic Lymphoma. Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH


How do plasma cells survive

B Cell Generation, Activation & Differentiation. B cell maturation

Basics of Immunology

Dendritic Cells: A Basic Review *last updated May 2003

LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5

From cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering

2) Macrophages function to engulf and present antigen to other immune cells.

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

T Cell Maturation,Activation and Differentiation

Waldenström Macroglobulinemia: The Burning Questions. IWMF Ed Forum May Morie Gertz MD, MACP

Continuing Medical Education Article Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias JNM, July 2012, Volume 53, Number 7


Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

KMS-Specialist & Customized Biosimilar Service

Introduction to Flow Cytometry

DELPHI 27 V 2016 CYTOMETRY STRATEGIES IN THE DIAGNOSIS OF HEMATOLOGICAL DISEASES

Things You Don t Want to Miss in Multiple Myeloma

A Focus on Multiple Myeloma

CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Proteins. Protein Trivia. Optimizing electrophoresis

SOUTHWEST ONCOLOGY GROUP CLINICAL RESEARCH ASSOCIATE (CRA) MANUAL. MYELOMA CHAPTER 10 REVISED: March 2008

Pathology No: SHS-CASE No. Date of Procedure: Client Name Address

Allergy and Immunology Review Corner: Chapter 21 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

CCR Biology - Chapter 9 Practice Test - Summer 2012

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

Flow Cytometric Evaluation of B-cell Lymphoid Neoplasms

Chapter 3. Immunity and how vaccines work

TCRG TCRA/D IGH IGK/L

The Body s Defenses CHAPTER 24

Understanding Serum Free Light Chain Assays

HemaCare Corporation Company Overview. Comprehensive Product and Service Solutions for BioResearch and Cellular Therapy

The Costimulatory Molecule CD27 Maintains Clonally

International Beryllium Conference, Montreal, Canada March 10, 2005

Subtypes of AML follow branches of myeloid development, making the FAB classificaoon relaovely simple to understand.

MONOCLONAL ANTIBODY PRODUCTION

REFERENCE CODE GDHCER PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA EPIDEMIOLOGY FORECAST TO 2023

The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small

Understanding Protein Electrophoresis

Drug Development Services

Hematology Morphology Critique

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

1.5 Function of analyte For albumin, see separate entry. The immunoglobulins are components of the humoral arm of the immune system.

Genomic Analysis of Mature B-cell Malignancies

Signaling monitoring and flow cytometry

Report series: General cancer information

Flow Cytometric Diagnosis of Low Grade B-cell Leukemia/Lymphoma

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy

The Journal of Experimental Medicine

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Transcription:

Multiple Myeloma and Colorectal Cancer From Systems Immunology to Single Cells Leo Hansmann Mark M. Davis Lab Department of Microbiology&Immunology Stanford University

Multiple Myeloma Monoclonal disease of plasma cells in the bone marrow The myeloma cells produce monoclonal immunoglobulin and/or light chains Develops from pre cancer diseases called monoclonal gammopathy of undetermined significance (MGUS) or asymptomatic myeloma (AM) Malignant plasma cells are not present in the peripheral blood UT Houston Morning Report Swerdlow et al.

CyTOF phenotyping panel surface markers TCR αβ TCR γδ CD3 CD4 CD8 CD7 CD28 CD57 CD25 CD19 CD24 CD10 CD5 CD27 IgD IgM CD38 CD5 CD14 CD16 CD11c CD123 CD1c CD56 HLA DR CD66 CD45 CD45RA CD45RO CCR7 functional/ intracellular markers CD20 IL4 IFNγ IL17A IFNα TNFα unstimulated PMA/Ionomycin R848 CpG2216/Dotap Dota malemide live/dead stain In total 39 markers stimuli conditions

PBMC phenotyping

Significant population frequency differences between study groups

Diversity of PBMC phenotypes in the peripheral blood MM (treatment naïve) MM (no treatment during the last 6M) pre cancer healthy

PCA separates MM from pre cancer and healthy controls MM (treatment naïve) MM (no treatment during the last 6M) pre cancer healthy

CD38 + CD24 lo CD27 + B cells contribute to PC1 in unstimulated cells and after PMA/Ionomycin stimulation

CD38 + CD24 lo CD27 + B cells in MM peripheral blood

CD38 + CD24 lo CD27 + B cells are uniquely expanded in MM peripheral blood

CD38 + CD24 lo CD27 + B cell expansion is associated with multiple myeloma activity

Citrus analysis of PBMC from MM patients and healthy controls

CD27 is significantly differentially expressed in PBMC subsets of MM patients when compared to healthy controls ** FDR<0.01

CD57 is significantly differentially expressed in PBMC subsets of MM patients when compared to healthy controls

Single cell sorting of CD24 lo CD38 + CD27 + B cells pre gated on CD19 + CD20 + B cells

Immunoglobulin light chain genes of CD24 lo CD38 + CD27 + B cells are polyclonal and show somatic mutations

Conclusions Multiple Myeloma CyTOF analysis of the immunological landscape in the states of cancer and pre cancer allows the detection of unique cancer associated phenotypes in human peripheral blood CD24 lo CD38 + CD27 + B cells are uniquely expanded in the peripheral blood of multiple myeloma patients The expansion of CD24 lo CD38 + CD27 + B cells is associated with multiple myeloma activity as measured by serum immunoglobulin light chain levels Single cell sequencing confirmed polyclonality and V gene mutations in these B cells most likely characterizing them as an expanded memory cell population with aberrant CD24 and CD38 expression Phosphorylation responses after B cell receptor or TLR 9 stimulation confirm the memory character of CD24 lo CD38 + CD27 + B cells

The single cell approach to TCR diversity and T cell plasticity a Single-Cell Sort Preamp Reaction: TCR primers + Cytokine primers + Transcription factor primers 1 TCR V (D) J C One-Step RT PCR with combined TCR +phenotype primers 1 Cytokine/ Transcription Factors 1 1 Reaction 1 CDR3 TCR sequencing, reactions 1 2 with barcoding Nested cytokine PCR + barcoding Nested PCR with combined TCR primers Nested PCR with combined phenotyping primers 2 1 2 1 V (D) J C 1 2 2 1 Reaction 2 Combine, Deep Sequence CDR3 Barcoding + Paired-End Addition for Deep Sequencing (TCR) Barcoding + Paired-End Addition for Deep Sequencing (phenotyping) 3 1 2 3 2 1 V (D) J C 3 3 1 2 2 1 Reaction 3 ~ 90% TCR sequencing efficiency CDR3 Combine, Purify, Sequence with Illumina MiSeq

Single T cell phenotyping

TILs from colorectal cancer show clonal expansion and distinct immune phenotypes Han et al. Nat Biotechnol 2014

TILs are phenotypically different from normal colon or peripheral blood T cells Han et al. Nat Biotechnol 2014

Conclusions Next generation sequencing allows the detailed identification of immune phenotypes along with TCR sequences in single tumor infiltrating lymphocytes CD4 + T cells infiltrating colorectal cancer show clonal expansion and distinct phenotypes in contrast to CD4 + T cells from non cancerous colon tissue Mass Cytometry and next generation sequencing allow immune phenotyping in extraordinary depth leading to The Identification of cancer associated immune phenotypes in peripheral blood and The detection of uniquely expanded T cell clones in the cancer microenvironment

Acknowledgements Davis Lab Mark Davis and Yueh hsiu Chien Arnold Han William O Gorman Cesar Angel Lopez Jacob Glanville All other Davis Lab members Robinson Lab Lisa Blum Scalfone Chia Hsin Ju Stanford Cancer Center Michaela Liedtke Lawrence Okumoto Stanford Cytogenetics Dana Bangs Vanderbilt Jonathan Irish